Court Extends Pre-Trial Order Deadline In Plavix Patent Suit

Law360 (February 23, 2005, 12:00 AM EST) -- A federal court has extended the pre-trial order submission deadline in a patent challenge to Sanofi-Aventis' blood-thinning drug Plavix.

The U.S. District Court for the Southern District of New York has approved an extension of the date for submission of the pre-trial order by the parties to April 8. The submission date had previously been scheduled for March 4, Sanofi-Aventis said.

All the parties in the litigation requested that that deadline be extended, Sanofi said in a statement.

Wednesday's is the second-extention of the pre-trial order...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.